Qiu-di Jiang

  • Citations Per Year
Learn More
OBJECTIVE To evaluate the efficacy and safety of human anti-interleukin-6 (IL-6) receptor antibody (tocilizumab) in combination with disease-modifying anti-rheumatoid drugs (DMARDs) for the treatment(More)
  • 1